These results were corroborated in a smaller case-control Swedish study which confirmed the aforementioned association with oxLDLs and demonstrated that anti-apoA-1 IgG levels were higher in RA patients than in control subjects and were higher in RA patients with a history of MACE when compared to those without [20]. The gene discussed is APOA1; the disease is rheumatoid arthritis.